France: In a recent pilot study, researchers are investigating the efficacy of phenolization as a treatment for sinus tracts ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven different scenarios: Pregnancy, breastfeeding, pediatrics, malignancy, tuberculosis ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while ...

Hidradenitis suppurativa (HS) is a chronic (long-term) condition that causes painful lesions under the skin. Many people take years to receive a proper HS diagnosis because it can look like ...

The following is a summary of “Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis,” published in the January 2025 issue of Dermatology by Trupiano et al. Itch ...

Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Hidradenitis suppurativa is a chronic inflammatory skin condition. Its recurrent, and it can be debilitating. Generally, we find it in skin fold areas, like armpits, groin area, perianal area ...

A cohort study suggests that people with hidradenitis suppurativa (HS) have twice the incidence of noninfectious uveitis (NIU) as controls, an association that remained significant after adjusting ...

Opens in a new tab or window Serum level of inflammatory marker C-reactive protein (CRP) predicted response to adalimumab (Humira) treatment for patients with hidradenitis suppurativa, post hoc ...

The Global Healthy Living Foundation (GHLF) announced today the launch of Your Interactive Patient Guide to Hidradenitis Suppurativa (HS), a groundbreaking resource designed to empower individuals ...